Speech-in-Noise Recognition With More Realistic Implementations of a Binaural Cochlear-Implant Sound Coding Strategy Inspired by the Medial Olivocochlear Reflex.


Journal

Ear and hearing
ISSN: 1538-4667
Titre abrégé: Ear Hear
Pays: United States
ID NLM: 8005585

Informations de publication

Date de publication:
Historique:
entrez: 2 11 2020
pubmed: 3 11 2020
medline: 29 7 2021
Statut: ppublish

Résumé

Cochlear implant (CI) users continue to struggle understanding speech in noisy environments with current clinical devices. We have previously shown that this outcome can be improved by using binaural sound processors inspired by the medial olivocochlear (MOC) reflex, which involve dynamic (contralaterally controlled) rather than fixed compressive acoustic-to-electric maps. The present study aimed at investigating the potential additional benefits of using more realistic implementations of MOC processing. Eight users of bilateral CIs and two users of unilateral CIs participated in the study. Speech reception thresholds (SRTs) for sentences in competition with steady state noise were measured in unilateral and bilateral listening modes. Stimuli were processed through two independently functioning sound processors (one per ear) with fixed compression, the current clinical standard (STD); the originally proposed MOC strategy with fast contralateral control of compression (MOC1); a MOC strategy with slower control of compression (MOC2); and a slower MOC strategy with comparatively greater contralateral inhibition in the lower-frequency than in the higher-frequency channels (MOC3). Performance with the four strategies was compared for multiple simulated spatial configurations of the speech and noise sources. Based on a previously published technical evaluation of these strategies, we hypothesized that SRTs would be overall better (lower) with the MOC3 strategy than with any of the other tested strategies. In addition, we hypothesized that the MOC3 strategy would be advantageous over the STD strategy in listening conditions and spatial configurations where the MOC1 strategy was not. In unilateral listening and when the implant ear had the worse acoustic signal-to-noise ratio, the mean SRT was 4 dB worse for the MOC1 than for the STD strategy (as expected), but it became equal or better for the MOC2 or MOC3 strategies than for the STD strategy. In bilateral listening, mean SRTs were 1.6 dB better for the MOC3 strategy than for the STD strategy across all spatial configurations tested, including a condition with speech and noise sources colocated at front where the MOC1 strategy was slightly disadvantageous relative to the STD strategy. All strategies produced significantly better SRTs for spatially separated than for colocated speech and noise sources. A statistically significant binaural advantage (i.e., better mean SRTs across spatial configurations and participants in bilateral than in unilateral listening) was found for the MOC2 and MOC3 strategies but not for the STD or MOC1 strategies. Overall, performance was best with the MOC3 strategy, which maintained the benefits of the originally proposed MOC1 strategy over the STD strategy for spatially separated speech and noise sources and extended those benefits to additional spatial configurations. In addition, the MOC3 strategy provided a significant binaural advantage, which did not occur with the STD or the original MOC1 strategies.

Identifiants

pubmed: 33136626
doi: 10.1097/AUD.0000000000000880
pii: 00003446-202011000-00008
pmc: PMC7722463
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1492-1510

Références

J Physiol. 1984 Sep;354:625-46
pubmed: 6481647
Ear Hear. 2002 Feb;23(1 Suppl):80S-89S
pubmed: 11883771
Int J Audiol. 2012 Jul;51(7):536-44
pubmed: 22537033
Trends Hear. 2015 Dec 30;19:
pubmed: 26721921
Ear Hear. 2008 Jan;29(1):20-32
pubmed: 18091099
Int J Audiol. 2016 Nov;55(11):674-87
pubmed: 27447758
J Speech Lang Hear Res. 2008 Apr;51(2):539-56
pubmed: 18367695
Science. 1983 Oct 7;222(4619):69-72
pubmed: 6623058
Nature. 1970 Jul 11;227(5254):184-5
pubmed: 5428410
J Acoust Soc Am. 1999 Mar;105(3):1821-30
pubmed: 10089605
Ear Hear. 2019 May/Jun;40(3):710-724
pubmed: 30204615
Hear Res. 2018 Nov;369:79-89
pubmed: 29759684
Audiol Neurootol. 2015;20 Suppl 1:3-6
pubmed: 25998698
J Physiol. 2006 Oct 1;576(Pt 1):49-54
pubmed: 16901947
World J Otorhinolaryngol Head Neck Surg. 2018 Jan 03;3(4):200-210
pubmed: 29780963
Trends Hear. 2015 Dec 30;19:
pubmed: 26721924
IEEE Trans Biomed Eng. 2007 Jun;54(6 Pt 1):969-72
pubmed: 17554816
Int J Audiol. 2008 Jun;47(6):369-70
pubmed: 18569112
Ear Hear. 2006 Dec;27(6):714-31
pubmed: 17086081
Trends Hear. 2015 Dec 30;19:
pubmed: 26721920
Hear Res. 2017 May;348:134-137
pubmed: 28188882
Adv Exp Med Biol. 2016;894:105-114
pubmed: 27080651
J Commun Disord. 1998 Nov-Dec;31(6):471-82; quiz 483; 553
pubmed: 9836136
PLoS One. 2014 Jan 20;9(1):e85756
pubmed: 24465686
Front Syst Neurosci. 2015 Jan 15;8:251
pubmed: 25642172
Physiol Rev. 2001 Jul;81(3):1305-52
pubmed: 11427697
Ear Hear. 2004 Jun;25(3):197-204
pubmed: 15179111
J Acoust Soc Am. 1998 Nov;104(5):2570-7
pubmed: 9821336
Hear Res. 2016 Aug;338:76-87
pubmed: 26828740
Nature. 1991 Jul 18;352(6332):236-8
pubmed: 1857418
J Acoust Soc Am. 2018 Apr;143(4):2217
pubmed: 29716283
J Acoust Soc Am. 2013 Feb;133(2):1004-16
pubmed: 23363117
J Acoust Soc Am. 2000 Feb;107(2):933-41
pubmed: 10687702
Hear Res. 1988 Sep 15;35(2-3):165-89
pubmed: 3198509
Hear Res. 2008 Aug;242(1-2):3-21
pubmed: 18616994
J Neurosci. 1996 Jan;16(1):325-32
pubmed: 8613799
J Assoc Res Otolaryngol. 2009 Sep;10(3):459-70
pubmed: 19263165
J Acoust Soc Am. 1994 Feb;95(2):1085-99
pubmed: 8132902
J Acoust Soc Am. 2006 May;119(5 Pt 1):2889-904
pubmed: 16708947
Tohoku J Exp Med. 2003 Jul;200(3):129-35
pubmed: 14521255
J Acoust Soc Am. 2015 Jul;138(1):319-31
pubmed: 26233032
J Assoc Res Otolaryngol. 2013 Jun;14(3):341-57
pubmed: 23423559
J Physiol. 2003 Apr 1;548(Pt 1):307-12
pubmed: 12611913
Ear Hear. 2005 Aug;26(4 Suppl):73S-81S
pubmed: 16082269
J Acoust Soc Am. 2009 Jan;125(1):372-83
pubmed: 19173424
Ear Hear. 2006 Dec;27(6):608-18
pubmed: 17086073
Ear Hear. 2016 May-Jun;37(3):e138-48
pubmed: 26862711
Front Neurol. 2018 Mar 26;9:197
pubmed: 29632514
Trends Hear. 2019 Jan-Dec;23:2331216519831492
pubmed: 30791832

Auteurs

Enrique A Lopez-Poveda (EA)

Laboratorio de Audición Computacional y Psicoacústica, Instituto de Neurociencias de Castilla y León, Universidad de Salamanca, Salamanca, Spain.
Grupo de Audiología, Instituto de Investigación Biomédica de Salamanca, Universidad de Salamanca, Salamanca, Spain.
Departamento de Cirugía, Facultad de Medicina, Universidad de Salamanca, Salamanca, Spain.

Almudena Eustaquio-Martín (A)

Laboratorio de Audición Computacional y Psicoacústica, Instituto de Neurociencias de Castilla y León, Universidad de Salamanca, Salamanca, Spain.
Grupo de Audiología, Instituto de Investigación Biomédica de Salamanca, Universidad de Salamanca, Salamanca, Spain.

Milagros J Fumero (MJ)

Laboratorio de Audición Computacional y Psicoacústica, Instituto de Neurociencias de Castilla y León, Universidad de Salamanca, Salamanca, Spain.
Grupo de Audiología, Instituto de Investigación Biomédica de Salamanca, Universidad de Salamanca, Salamanca, Spain.

José M Gorospe (JM)

Laboratorio de Audición Computacional y Psicoacústica, Instituto de Neurociencias de Castilla y León, Universidad de Salamanca, Salamanca, Spain.
Grupo de Audiología, Instituto de Investigación Biomédica de Salamanca, Universidad de Salamanca, Salamanca, Spain.
Departamento de Cirugía, Facultad de Medicina, Universidad de Salamanca, Salamanca, Spain.
Unidad de Foniatría, Logopedia y Audiología, Servicio de Otorrinolaringología, Hospital Universitario de Salamanca, Salamanca, Spain.

Rubén Polo López (R)

Servicio de Otorrinolaringología, Hospital Universitario Ramón y Cajal, Madrid, Spain.

M Auxiliadora Gutiérrez Revilla (MA)

Servicio de Otorrinolaringología, Hospital Universitario Ramón y Cajal, Madrid, Spain.

Reinhold Schatzer (R)

MED-EL GmbH, Innsbruck, Austria.

Peter Nopp (P)

MED-EL GmbH, Innsbruck, Austria.

Joshua S Stohl (JS)

North American Research Laboratory, MED-EL Corporation, Durham, North Carolina, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH